阻尼胶囊的生产工艺研究

通过对胶料配方、工艺规程、模具结构的试验研究，成功地解决了胶囊制造过程中的难点问题。     

以表面负载季铵盐阳离子型苯/丙乳胶粒为模板制备ZrO_2空心微球

以C9油与甲基丙烯酰氧乙基三甲基氯化胺的共聚物P(C9-DMC)为乳化剂制备苯/丙阳离子乳胶粒,并以其为模板,利用直接包覆法制备了由17 nm左右微晶体堆成的ZrO2空心微球。所制得的样品采用FT-IR、XRD、TEM和SEM等进行了表征。     

用SBR1502胶浆制取道路沥青改性用胶乳

用附聚法和降粘法浓缩ＳＢＲ１５０２胶浆制取道路沥青改性用胶乳。结果表明：总固物质量分数可由（２１±２）％上升到４５％～５０％。该胶乳与齐鲁石化公司炼油厂１００号乙沥青混合，改性后的道路沥青具有良好的使用性能，可满足高等级路面沥青的技术要求。     

高透明耐冲击聚氯乙烯接枝聚合研究

研究高透明耐冲击聚氯乙烯接枝聚合工艺，讨论了加料顺序、复合分散体系以及采用聚集粒子乳液、并用碱性物质调节其ｐＨ值等对接枝聚合物性能的影响，确定了接枝聚合最佳工艺条件。     

改性膨润土对天然橡胶的力学性能影响研究

本文讨论了改性膨润土对天然橡胶的力学性能的影响，并同未改性膨润土及白炭黑作了比较。用Ｘ光衍射仪和红外光谱分析了膨润土改性前后的结构变化。     

丁苯胶乳改性道路沥青的推广应用

用丁苯胶乳对胜利１００号沥青进行改性试验．发现随着胶乳掺量的增加．沥青的高温性能、粘结性能改善幅度也大。但综合考虑沥青生产成本等因素．认为：对丁苯胶乳改性胜利１００号道路沥青．掺胶量控制在２％即可满足一般高等级道路工程的需要。文中还介绍了丁苯胶乳沥青近年来的推广使用情况并做了相应的技术经济分析和建议。     

乳胶漆的市场现状和发展前景

对乳胶漆的生产现状，产品结构以及研究开发情况作了简单的综述，并展望了乳胶漆的发展前景。     

A comparative study of short nylon fiber—Natural rubber composites prepared from dry rubber and latex masterbatch

A novel method for the preparation of short nylon fiber–natural rubber composites was developed in which short fibers chopped to approximately 6 mm were incorporated in the latex stage and processed into sheet form. By this method, mixing cycle time was reduced without compromising the fiber dispersion. Fiber breakage during mixing was reduced. The new composites when compounded with a dry bonding system based on hexamethylenetetramine, resorcinol and hydrated silica (HRH) showed improved modulus, tensile strength and abrasion resistance compared to conventional composites. Tear strength, resilience, and compression set were similar to the conventional composites. SEM analysis indicated better interaction between matrix and fibers in the case of latex master batch. © 2008 Wiley Periodicals, Inc. J Appl Polym Sci, 2008     

Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process

Aging is a phenomenon underlined by complex molecular and biochemical changes that occur over time. One of the metabolites that is gaining strong research interest is nicotinamide adenine dinucleotide, NAD⁺, whose cellular level has been shown to decrease with age in various tissues of model animals and humans. Administration of NAD⁺ precursors, nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), to supplement NAD⁺ production through the NAD⁺ salvage pathway has been demonstrated to slow down aging processes in mice. Therefore, NAD⁺ is a critical metabolite now understood to mitigate age-related tissue function decline and prevent age-related diseases in aging animals. In human clinical trials, administration of NAD⁺ precursors to the elderly is being used to address systemic age-associated physiological decline. Among NAD⁺ biosynthesis pathways in mammals, the NAD⁺ salvage pathway is the dominant pathway in most of tissues, and NAMPT is the rate limiting enzyme of this pathway. However, only a few activators of NAMPT, which are supposed to increase NAD⁺, have been developed so far. In this review, we will focus on the importance of NAD⁺ and the possible application of an activator of NAMPT to promote successive aging.